Envision Healthcare Holdings Rating Reiterated by Barclays (EVHC)
Envision Healthcare Holdings (NASDAQ:EVHC)‘s stock had its “overweight” rating reiterated by Barclays in a research note issued on Thursday, StockRatingsNetwork.com reports. They currently have a $40.00 price target on the stock, up from their previous price target of $39.00. Barclays’ price target would indicate a potential upside of 16.25% from the company’s current price.
Shares of Envision Healthcare Holdings (NASDAQ:EVHC) traded down 1.25% during mid-day trading on Thursday, hitting $33.98. 307,086 shares of the company’s stock traded hands. Envision Healthcare Holdings has a 52 week low of $24.62 and a 52 week high of $36.80. The stock has a 50-day moving average of $33.30 and a 200-day moving average of $32.. The company has a market cap of $6.155 billion and a P/E ratio of 860.25.
Envision Healthcare Holdings (NASDAQ:EVHC) last announced its earnings results on Wednesday, May 7th. The company reported $0.20 earnings per share for the quarter, beating the analysts’ consensus estimate of $0.19 by $0.01. The company had revenue of $1.01 billion for the quarter, compared to the consensus estimate of $1.02 billion. During the same quarter last year, the company posted ($0.03) earnings per share. Envision Healthcare Holdings’s revenue was up 14.2% compared to the same quarter last year. On average, analysts predict that Envision Healthcare Holdings will post $1.11 earnings per share for the current fiscal year.
EVHC has been the subject of a number of other recent research reports. Analysts at Morgan Stanley reiterated an “overweight” rating on shares of Envision Healthcare Holdings in a research note on Thursday. They now have a $33.00 price target on the stock. Separately, analysts at Piper Jaffray raised their price target on shares of Envision Healthcare Holdings from $38.00 to $40.00 in a research note on Thursday. Finally, analysts at UBS AG raised their price target on shares of Envision Healthcare Holdings from $37.00 to $40.00 in a research note on Monday, April 7th. They now have a “buy” rating on the stock. Three analysts have rated the stock with a hold rating and twelve have given a buy rating to the company. The stock currently has an average rating of “Buy” and a consensus target price of $47.13.
Envision Healthcare Holdings, Inc, is a provider of physician-led, outsourced medical services in the United States.
Get Analysts' Upgrades and Downgrades via Email - Stay on top of analysts' coverage with Analyst Ratings Network's FREE daily email newsletter that provides a concise list of analysts' upgrades and downgrades. Click here to register now.